From: Tissue engineering strategies for the induction of angiogenesis using biomaterials
Approach | Advantage | Limitation | Ref |
---|---|---|---|
Scaffolds | • Carrying cells • Delivery pro-angiogenic factors • Providing 3D condition • Having stability | • Timely degradation • Toxicity • Immune-modulatory effects | |
Stem cell priming or pretreatment | • Improve differentiation rate • Improve migration and homing rate to target tissue • Improve cell function | • Cellular senescence • Critical consideration for cell treatment | |
Exosomes | • Bio-shuttle for pro- and anti-angiogenic factors • Lack of immune-privileged capacity | • Promotes tumorgenesis • Needs to isolate and concentrated | |
Magnetic enhancement techniques | • Facilitate the cell retention rate • Control cells mobilization into target sites • Track transplanted cells in in vivo | • Provide micro-emboli for cells with small size features | |
Ultrasound techniques | • Enhance delivery of cells to target sites | • Yields cytotoxicity by promoting necrosis or apoptosis • Tissue damage such as arrhythmias, endothelium malfunction such as capillary leakage | |
Enhanced homing technique | • Enhance proliferating, migrating, and alignment of EPCs to target sites | ND* | |
Mannitol-enhanced delivery | • Used for cell delivery through the blood-brain barrier | • Being selective for distinct cells and factors |